Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Keks

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Medical Journal of Australia|May 18, 1999
Psychotropic drug prescribing: first the good newsN A Keks, G D Burrows
The Medical Journal of Australia|October 16, 1989
Treatment of schizophreniaN A Keks, J Kulkarni, D L Copolov
The Medical Journal of Australia|November 1, 1993
Initial Australian experience with the atypical antipsychotic clozapineN A Keks, D L Copolov, G Johnson
The American Journal of Psychiatry|October 1, 1987
Abnormal prolactin response to haloperidol challenge in men with schizophreniaN A Keks, D L Copolov, B S Singh
The Medical Journal of Australia|September 4, 1999
Abnormal involuntary movements in people with schizophrenia in the communityJ D Hope, N A Keks, T L Sacks, et al.
The Australian and New Zealand Journal of Psychiatry|March 1, 1992
The diagnostic validity of paraphreniaA M Hassett, N A Keks, H J Jackson, et al.
The Medical Journal of Australia|October 7, 1997
Collaboration between general practice and community psychiatric services for people with chronic mental illnessN A Keks, B M Altson, T L Sacks, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: I. Meta-analysis of efficacy and safetyA Davies, M A Adena, N A Keks, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: II. Cost-effectivenessA Davies, P C Langley, N A Keks, et al.
The Australian and New Zealand Journal of Psychiatry|September 1, 1992
Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patientsC Hill, N A Keks, H Jackson, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Medical Journal of Australia|May 18, 1999
Psychotropic drug prescribing: first the good newsN A Keks, G D Burrows
The Medical Journal of Australia|October 16, 1989
Treatment of schizophreniaN A Keks, J Kulkarni, D L Copolov
The Medical Journal of Australia|November 1, 1993
Initial Australian experience with the atypical antipsychotic clozapineN A Keks, D L Copolov, G Johnson
The American Journal of Psychiatry|October 1, 1987
Abnormal prolactin response to haloperidol challenge in men with schizophreniaN A Keks, D L Copolov, B S Singh
The Medical Journal of Australia|September 4, 1999
Abnormal involuntary movements in people with schizophrenia in the communityJ D Hope, N A Keks, T L Sacks, et al.
The Australian and New Zealand Journal of Psychiatry|March 1, 1992
The diagnostic validity of paraphreniaA M Hassett, N A Keks, H J Jackson, et al.
The Medical Journal of Australia|October 7, 1997
Collaboration between general practice and community psychiatric services for people with chronic mental illnessN A Keks, B M Altson, T L Sacks, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: I. Meta-analysis of efficacy and safetyA Davies, M A Adena, N A Keks, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: II. Cost-effectivenessA Davies, P C Langley, N A Keks, et al.
The Australian and New Zealand Journal of Psychiatry|September 1, 1992
Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patientsC Hill, N A Keks, H Jackson, et al.
Pageof 3